Reference
Woodcock J. Statement on the agency's ongoing efforts to resolve safety issue with ARB medications. Internet Document : 28 Aug 2019. Available from: URL: https://www.fda.gov/news-events/press-announcements/statement-agencys-ongoing-efforts-resolve-safety-issue-arb-medications
Rights and permissions
About this article
Cite this article
Nitrosamine impurities in angiotensin receptor blockers. Reactions Weekly 1770, 4 (2019). https://doi.org/10.1007/s40278-019-67439-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-67439-x